Chiara Mercinelli

11PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanomaterialsNeurology and neuromuscular diseasesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 31, 2026
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.

|Dec 30, 2025
The Management of Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives.

Antonio Cigliola, Brigida Anna Maiorano, Doga Dengur

|Jun 20, 2025
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.

Valentina Tateo, Joep J de Jong, Antonio Cigliola

|May 22, 2025
Zelenectide pevedotin (BT-8009): a bicyclic peptide toxin conjugate targeting nectin-4 for the treatment of bladder cancer.

Antonio Cigliola, Valentina Tateo, Michela Ravasi

|Dec 24, 2024
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI.

Giorgio Brembilla, Giuseppe Basile, Michele Cosenza

|Dec 03, 2024
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.

Emanuele Crupi, Tiago Costa de Padua, Laura Marandino

Pageof 2

Frequent Collaborators

8 joint publications

Antonio Cigliola

6 joint publications

Andrea Necchi

6 joint publications

Valentina Tateo

4 joint publications

Brigida Anna Maiorano